# Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma

> **NCT05472766** · NA · TERMINATED · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 1 (actual)

## Conditions studied

- Subdural Hematoma
- Atrial Fibrillation

## Interventions

- **DRUG:** Direct Acting Oral Anticoagulant starting at Day 30
- **DRUG:** Direct Acting Oral Anticoagulant starting at Day 90

## Key facts

- **NCT ID:** NCT05472766
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-11-24
- **Primary completion:** 2024-03-22
- **Final completion:** 2024-05-10
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study terminated due to logistical challenges in conducting the trial.
- **Last updated:** 2024-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05472766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05472766, "Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05472766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*